spot_img
spot_img
Wednesday, December 8, 2021
spot_img
spot_img

Latest Posts

Covaxin approved for children below 18 years

spot_img
spot_img
- Advertisement -

Great news for India’s health, as Covid-19 vaccine, Covaxin for children aged between 2 to 18 years, gains approval.

Covaxin is developed and manufactured by Bharat Biotech. The vaccine aims at protecting against COVID-19. Emergency use approval has been provided to Covaxin for use on children of the age group 2 to 18 years.

Bharat Biotech International Limited is an Indian multinational biotechnology company based in Hyderabad.

approv Covaxin

The company in September 2021, had completely carried out Phase-II and Phase-III trials of its vaccine, Covaxin, on children below 18 years of age. It had submitted the trial to the Drugs and Comptroller General of India (DCGI) in the beginning of October.

Also Read: ONE IN SEVEN INDIANS AGED 15 TO 24 YEARS OLD IS DEPRESSED: UNICEF

Latest Posts

spot_imgspot_img

Don't Miss

Stay in touch

To be updated with all the latest news, offers and special announcements.